Will Natco and Dr. Reddy’s bet on weight-loss drug Ozempic’s copy pay off?
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
‘We made 434pc on one stock – now we’re hunting for the next Ozempic’
Fund Of The Week quizzes fund managers about how they’re investing your money. If you’d like to suggest which funds you want ...
European shares tipped to soar as US investors pile in - experts reveal the cheap stocks they would buy
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
MarketBeat on MSN22h
These 3 Stocks Just Announced Major Dividend Hikes
These three stocks just announced significant quarterly dividend increases that they are set to pay out soon. While they all ...
European stocks are set to soar as US investors pile in. Here the world's top experts reveal the dirt-cheap stocks that could make YOU a packet
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
Man, 52, ‘cured’ of his 15-year cocaine habit after taking weight loss jab in first case of its kind
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
VEA vs VWO: Which International Vanguard ETF Is Worth Owning?
After President Donald Trump’s November 2024 election victory, the Financial Times had reported $140 billion new investment into US equity funds in just the first month. While there is certainly cause ...
Le Lézard19h
Employer-Sponsored GLP-1 Coverage Becomes Critical for Talent Retention and Acquisition, New 9amHealth Survey Finds
As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey results from 9amHealth reveal that access to these medications has become a ...
Zacks Small Cap Research on MSN19h
RANI: Impressive Bioavailability for RT-116
RANI READ THE FULL RANI RESEARCH REPORT On February 5th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...
Novo Nordisk call volume above normal and directionally bullish
Bullish option flow detected in Novo Nordisk (NVO) with 21,940 calls trading, 1.5x expected, and implied vol increasing almost 3 points to ...